Background: Peptidylarginine deiminase 2 (PAD2) and peptidylarginine deiminase 4 (PAD4) are two members of PAD family which are over-expressed in the multiple sclerosis (MS) brain. Through its enzymatic activity PAD2 converts myelin basic protein (MBP) arginines into citrullines – an event that may favour autoimmunity – while peptidylarginine deiminase 4 (PAD4) is involved in chromatin remodelling.
Objectives: Our aim was to verify whether an altered epigenetic control of PAD2, as already shown in the MS brain, can be observed in peripheral blood mononuclear cells (PBMCs) of patients with MS since some of these cells also synthesize MBP.
Methods: The expression of most suitable reference genes and of PAD2 and PAD4 was assessed by qPCR. Analysis of DNA methylation was performed by bisulfite method.
Results: The comparison of PAD2 expression level in PBMCs from patients with MS vs. healthy donors showed that, as well as in the white matter of MS patients, the enzyme is significantly upregulated in affected subjects. Methylation pattern analysis of a CpG island located in the PAD2 promoter showed that over-expression is associated with promoter demethylation.
Conclusion: Defective regulation of PAD2 in the periphery, without the immunological shelter of the blood–brain barrier, may contribute to the development of the autoimmune responses in MS.
BoggsJM. Myelin basic protein: a multifunctional protein. Cell Mol Life Sci2006; 63: 1945–1961.
3.
MastronardiFGNoorAWoodDDPatonTMoscarelloMA. Peptidyl argininedeiminase 2 CpG island in multiple sclerosis white matter is hypomethylated. J Neurosci Res2007; 85: 2006–2016.
4.
Casaccia-BonnefilPPandozyGMastronardiF. Evaluating epigenetic landmarks in the brain of multiple sclerosis patients: a contribution to the current debate on disease pathogenesis. Prog Neurobiol2008; 86: 368–378.
5.
KurtuncuMTuzunE. Multiple sclerosis: could it be an epigenetic disease?Med Hypotheses2008; 71: 945–947.
6.
UrdinguioRGSanchez-MutJVEstellerM. Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies. Lancet Neurol2009; 8: 1056–1072.
7.
MusseAALiZAckerleyCABienzleDLeiHPomaR. Peptidylarginine deiminase 2 (PAD2) overexpression in transgenic mice leads to myelin loss in the central nervous system. Dis Model Mech2008; 1: 229–240.
8.
VoskuhlRR. Myelin protein expression in lymphoid tissues: implications for peripheral tolerance. Immunol Rev1998; 164: 81–92.
9.
WangYWysockaJSayeghJLeeYHPerlinJRLeonelliL. Human PAD4 regulates histone arginine methylation levels via demethylimination. Science2004; 306: 279–283.
10.
MastronardiFGWoodDDMeiJRaijmakersRTsevelekiVDoschHM. Increased citrullination of histone H3 in multiple sclerosis brain and animal models of demyelination: a role for tumor necrosis factor-induced peptidylarginine deiminase 4 translocation. J Neurosci2006; 26: 11387–11396.
11.
WoodDDAckerleyCABrandBZhangLRaijmakersRMastronardiFG. Myelin localization of peptidylarginine deiminases 2 and 4: comparison of PAD2 and PAD4 activities. Lab Invest2008; 88: 354–364.
12.
ChangXYamadaRSuzukiASawadaTYoshinoSTokuhiroS. Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis. Rheumatology2005; 44: 40–50.
13.
VossenaarERRadstakeTRvan der HeijdenAvan MansumMADieterenCde RooijDJ. Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages. Ann Rheum Dis2004; 63: 373–381.
14.
ZampieriMCiccaroneFGuastafierroTBacaliniMGCalabreseRMoreno-VillanuevaM. Validation of suitable internal control genes for expression studies in aging. Mech Ageing Dev2010; 131: 89–95.
15.
MoscarelloMAMastronardiFGWoodDD. The role of citrullinated proteins suggests a novel mechanism in the pathogenesis of multiple sclerosis. Neurochem Res2007; 32: 251–256.
16.
VandesompeleJDe PreterKPattynFPoppeBVan RoyNDe PaepeA. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol2002; 3: RESEARCH0034.
17.
AndersenCLJensenJLOrntoftTF. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res2004; 64: 5245–5250.
18.
VossenaarERZendmanAJvan VenrooijWJPruijnGJ. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays2003; 25: 1106–1118.
19.
PritzkerLBJoshiSGowanJJHarauzGMoscarelloMA. Deimination of myelin basic protein. 1. Effect of deimination of arginyl residues of myelin basic protein on its structure and susceptibility to digestion by cathepsin D. Biochemistry2000; 39: 5374–5381.
20.
Carrillo-VicoALeechMDAndertonSM. Contribution of myelin autoantigen citrullination to T cell autoaggression in the central nervous system. J Immunol2010; 184: 2839–2846.
21.
MacKenzie-GrahamAJPribylTMKimSPorterVRCampagnoniATVoskuhlRR. Myelin protein expression is increased in lymph nodes of mice with relapsing experimental autoimmune encephalomyelitis. J Immunol1997; 159: 4602–4610.
22.
TranquillLRCaoLLingNCKalbacherHMartinRMWhitakerJN. Enhanced T cell responsiveness to citrulline-containing myelin basic protein in multiple sclerosis patients. Mult Scler2000; 6: 220–225.
23.
DeraosGChatzantoniKMatsoukasMTTseliosTDeraosSKatsaraM. Citrullination of linear and cyclic altered peptide ligands from myelin basic protein (MBP(87-99)) epitope elicits a Th1 polarized response by T cells isolated from multiple sclerosis patients: implications in triggering disease. J Med Chem2008; 51: 7834–7842.
24.
de SezeJDubucquoiSLefrancDVirecoulonFNuezIDutoitV. IgG reactivity against citrullinated myelin basic protein in multiple sclerosis. J Neuroimmunol2001; 117: 149–155.
25.
KurreemanFLiaoKChibnikLHickeyBStahlEGainerV. Genetic basis of autoantibody positive and negative rheumatoid arthritis risk in a multi-ethnic cohort derived from electronic health records. Am J Hum Genet2011; 88: 57–69.
26.
ShimoyamaSNagadoiATachiwanaHYamadaMSatoMKurumizakaH. Deimination stabilizes histone H2A/H2B dimers as revealed by electrospray ionization mass spectrometry. J Mass Spectrom2010; 45: 900–908.
27.
ManolioTACollinsFSCoxNJGoldsteinDBHindorffLAHunterDJ. Finding the missing heritability of complex diseases. Nature2009; 461: 747–753.
